The Predictive Role of Programmed Death Ligand 1 (PD-L1) and Neutrophil to Lymphocyte Ratio (NLR) in Non-Small Cell Lung Cancer (NSCLC)

NCT03816657 · clinicaltrials.gov ↗

UNKNOWN

Status

93

Enrollment

OTHER

Sponsor class

Conditions

To Define an Easy and Feasible Panel Which May be Routinely Applied to Select Patients for Immunotherapy Avoiding More Complex and Expensive Methods

Sponsor

Fondazione Ricerca Traslazionale